PUBLISHER: The Business Research Company | PRODUCT CODE: 1939271
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939271
An artificial kidney is a mechanical device or system created to replicate the functions of a healthy kidney, specifically designed for individuals suffering from end-stage renal disease (ESRD) or kidney failure. Operating externally to the body, it serves as a substitute kidney by eliminating waste from circulation and regulating calcium ion absorption and red blood cell production.
The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.
Tariffs are influencing the artificial kidney market by increasing costs of imported membranes, sensors, electronic control units, and biocompatible materials used in dialysis systems. Healthcare providers in North America and Europe are most affected due to reliance on imported medical components, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing treatment equipment costs and slowing device upgrades. However, they are also promoting domestic manufacturing, localized component sourcing, and long-term innovation in artificial kidney technologies.
The artificial kidney market research report is one of a series of new reports from The Business Research Company that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with a artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial kidney market size has grown rapidly in recent years. It will grow from $11.43 billion in 2025 to $12.91 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increasing prevalence of end-stage renal disease, expansion of dialysis treatment centers, advancements in dialysis membrane technology, rising adoption of home dialysis options, improved survival rates of renal patients.
The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $21.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in bioengineered kidney research, rising demand for portable dialysis solutions, expansion of remote patient monitoring, growing focus on reducing dialysis dependency, technological progress in artificial organ development. Major trends in the forecast period include increasing development of wearable dialysis systems, rising focus on implantable artificial kidney solutions, growing integration of smart monitoring in dialysis devices, expansion of home-based dialysis technologies, enhanced emphasis on patient mobility and comfort.
The sharp rise in chronic kidney disease cases is anticipated to accelerate the growth of the artificial kidney market in the coming years. Chronic kidney disease is a persistent medical condition in which kidney function progressively deteriorates over time. Artificial kidneys are widely used in the management of chronic kidney disease, as they help eliminate waste materials and toxins from the bloodstream, prevent fluid buildup, and maintain a healthy balance of electrolytes in the body. For example, in June 2023, Kidney Research UK reported that approximately 7.19 million people in the UK were living with chronic kidney disease in 2023, accounting for over 10% of the population, with projections indicating an increase to 7.61 million individuals by 2033. As a result, the growing prevalence of chronic kidney disease is contributing significantly to the expansion of the artificial kidney market.
Leading players in the artificial kidney market are increasingly prioritizing advanced solutions such as wearable sorbent-regeneration dialysis technologies to improve patient mobility, treatment adaptability, and overall quality of life. This technology employs a compact system that continuously purifies and recycles dialysate using sorbent cartridges, enabling portable and continuous dialysis, substantially lowering dialysate volume requirements, and allowing greater patient independence. For instance, in June 2023, AWAK Technologies, a medical technology firm based in Singapore, introduced AWAK PD, a wearable sorbent-regeneration peritoneal dialysis system developed to enable patients with end-stage kidney disease to receive dialysis while staying mobile. The device incorporates an ultra-lightweight three-kilogram design, a patented sorbent-based dialysate regeneration mechanism that cuts fluid usage by up to 90%, and a configuration recognized under the FDA Breakthrough Device program. AWAK PD enhances treatment convenience, supports patient mobility, and improves the overall dialysis experience.
In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.
Major companies operating in the artificial kidney market are Fresenius SE and Co. KGaA, Medtronic plc, Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation, Nikkiso Co. Ltd., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V., Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation
North America was the largest region in the artificial kidney market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Kidney Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial kidney market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial kidney ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial kidney market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.